Fortress Biotech Inc.

05/24/2022 | Press release | Distributed by Public on 05/24/2022 06:32

Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity